NCT05765812 2026-03-30A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed GlioblastomaDebiopharm International SAPhase 1/2 Recruiting116 enrolled
NCT03452774 2025-10-28SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryMassive Bio, Inc.Recruiting50,000 enrolled
NCT00935090 2025-07-083'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With CancerBarbara Ann Karmanos Cancer InstituteRecruiting
NCT06815029 2025-06-26Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant AstrocytomaCity of Hope Medical CenterPhase 1 Recruiting27 enrolled